Phibro Animal Health (PAHC) Interest Coverage Ratio (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Interest Coverage Ratio came in at 4.18 in Q1 2026, up 20.41% year-on-year from 3.47 in Q1 2025, and up 3.68% quarter-over-quarter from 4.03 in Q4 2025.
Phibro Animal Health (PAHC) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Phibro Animal Health's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 4.18 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 20.41% year-over-year to 4.18 in Q1 2026; TTM through Mar 2026 was 4.02, a 44.55% increase from a year earlier, with the FY2025 full-year figure at 2.97, up 28.08% from the prior year.
- Interest Coverage Ratio improved to 4.18 in Q1 2026 per PAHC's latest filing, from 4.03 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 12.17 in Q2 2022 and bottomed at 0.13 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 3.7 (2022), against an average of 3.94.
- Across the five-year window, Interest Coverage Ratio sank 103.47% in 2023 and surged 1670.09% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 3.42 in 2022, then slipped by 19.86% to 2.74 in 2023, then retreated by 4.82% to 2.61 in 2024, then surged by 54.42% to 4.03 in 2025, then climbed by 3.68% to 4.18 in 2026.
- Per Business Quant, the three latest PAHC Interest Coverage Ratio figures stand at 4.18 (Q1 2026), 4.03 (Q4 2025), and 4.09 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 4.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.18 |
| Dec 31, 2025 | 4.03 |
| Sep 30, 2025 | 4.09 |
| Jun 30, 2025 | 3.73 |
| Mar 31, 2025 | 3.47 |
| Dec 31, 2024 | 2.61 |
| Sep 30, 2024 | 2.02 |
| Jun 30, 2024 | 3.07 |
| Mar 31, 2024 | 3.53 |
| Dec 31, 2023 | 2.74 |
| Sep 30, 2023 | -0.13 |
| Jun 30, 2023 | 4.36 |
| Mar 31, 2023 | 3.78 |
| Dec 31, 2022 | 3.42 |
| Sep 30, 2022 | 3.70 |
| Jun 30, 2022 | 12.17 |
| Mar 31, 2022 | 6.17 |
| Dec 31, 2021 | 7.19 |
| Sep 30, 2021 | 4.77 |
| Jun 30, 2021 | 4.73 |